after
correction for multiple
testing was applied, and each of these combinations included CXCL13 rs
PARFENOV, E.V.,
MUKAEVA, V.R.,
FARRAKHOV, R.G.,
PARFENOVA, L.V.,
LUKINA, E.S.,
DYAKONOV, G.S.,
VALIEV, R.Z.,
DANILKO, K.V. (2019) presencein the PEO coating pores was proven by the EIS. For the in vitro
tests, fibroblasts were used
Bovell-Ammon, B.J.,
Kimmel, S.D.,
Cheng, D.M.,
Truong, V.,
Michals, A.,
Vetrova, M.,
Hook, K.,
Idrisov, B.,
Blokhina, E.,
Krupitsky, E.,
Samet, J.H.,
Lunze, K. (2023) (PWH)
who inject
drugs in Russia have not been well described.
Methods: We conducted a cross